#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA963040	B	Initial binding affinity to wild type human PNP	Homo sapiens	10		single protein format	Scientific Literature
2.	ALA963041	B	Equilibrium binding affinity to wild type human PNP	Homo sapiens	10		single protein format	Scientific Literature
3.	ALA963043	B	Ratio of Km for wild type human PNP to Ki for wild type human PNP relative to inosine	Homo sapiens	10		single protein format	Scientific Literature
4.	ALA963045	B	Equilibrium binding affinity to human PNP His257Gly mutant	Homo sapiens	10		assay format	Scientific Literature
5.	ALA963047	B	Ratio of Km for human PNP His257Gly mutant to Ki for human PNP His257Gly mutant relative to inosine	Homo sapiens	10		assay format	Scientific Literature
6.	ALA963048	B	Ratio of relative binding Km/Ki for wild type human PNP to relative binding affinity Km/Ki for human PNP His257Gly mutant	Homo sapiens	10		assay format	Scientific Literature
7.	ALA963049	B	Selectivity for Plasmodium falciparum PNP over human PNP		2		assay format	Scientific Literature
8.	ALA960618	B	Initial binding affinity to human PNP His257Gly mutant	Homo sapiens	9		assay format	Scientific Literature
9.	ALA3888213	B	Inhibition Assay: Assays for slow-onset inhibitors were carried out by adding 1 nM PaMTIP into reaction mixtures at 25 °C. containing 100 mM Hepes, pH 7.4, 100 mM phosphate, pH 7.4, 2 mM MTI, 5 mM DTT, 0.5 unit of xanthine oxidase and variable inhibitor concentration. Inhibitors were present at >10 times the enzyme concentration. Assays for MTA inhibition used 200 μM MTI. Controls having no enzyme and no inhibitor were included in all of the inhibition assays. Slow-onset inhibitors display a second phase of tighter binding after reaching a thermodynamic equilibrium with the enzyme. The equilibrium constant for the second binding phase is indicated as Ki*.		8		single protein format	BindingDB Database